121/399US=60 / Biol/Mol
Leung KC, Chen GG. Cyclooxygenase 2 and its metabolites: implications for lung cancer therapy. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 251-72. ISBN 978-1-4020-9596-2.

APOPTOSE; MORTE CELULAR PROGRAMADA; CANCER DE PULMAO; CICLOOXIGENASE 2; PROSTAGLANDINA; COX-2; QUIMIOTERAPIA


122/399US=60 / Biol/Mol
Lee MH, Yang H, Zhao R, Yeung SCJ. Roles of negative and positive growth regulators in nasopharyngeal carcinoma. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 273-94. ISBN 978-1-4020-9596-2.

APOPTOSE; MORTE CELULAR PROGRAMADA; CANCER NASOFARINGEO; REGULADORES DE CRESCIMENTO; CICLO CECLULAR; CARCINOMA NASOFARINGEO; SINALIZACAO DE TRANSDUCAO; REGULADORES DE CRESCIMENTO NEGATIVO; REGULADORES DE CRESCIMENTO POSITIVO


123/399US=60 / Biol/Mol
Alin N, MacLeod S, Hine RJ, Chowdhury P. Cellular signaling mechanisms in pancreatic apoptosis. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 295-325. ISBN 978-1-4020-9596-2.

APOPTOSE; MORTE CELULAR PROGRAMADA; MECANISMOS DE SINALIZACAO DE APOPTOSE; FOSFATOS DE INOSITOL; NUTRICAO; CARCINOGENESE PANCREATICA; CANCER DE PANCREAS; BIOMARCADORES; INIBIDORES DE CASPASES; FAMILIA IAP; MECANISMOS ACOPLADOS A PROTEINA- G; POLIFOSFATOS DE INOSITOL; BIOMARCADORES; DIETA; ESTRESSE OXIDATIVO


124/399US=60 / Biol/Mol
Dinnen RD, Petrylak DP, Fine RL. Strategies to circumvent resistance to apoptosis in prostate cancer cells by targeted necrosis. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 327-46. ISBN 978-1-4020-9596-2.

APOPTOSE; MORTE CELULAR PROGRAMADA; RESISTENCIA A APOPTOSE; CANCER DE PROSTATA; NECROSE; P53; ESPECIES REATIVAS DE OXIGENIO


125/399US=60 / Biol/Mol
Liu ZM, Chen GG. Carcinogenesis and therapeutic strategies for thyroid cancer. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 347-74. ISBN 978-1-4020-9596-2.

APOPTOSE; MORTE CELULAR PROGRAMADA; CARCINOGENESE; CANCER DA TIREOIDE; TERAPIA ANTI-CANCER; ANGIOGENESE


126/399US=89 / Biol/Mol
Opyrchal M, Aderca I, Galanis E. Phase I clinical trial of locoregional administration of the oncolytic adenovirus ONYX-015 in combination with mitomycin-C, doxorubicin, and cisplatin chemotherapy in patients with advanced sarcomas. In: Walther W, Stein US. Gene therapy of cancer: methods and protocols. 2ª ed. New Jersey: Humana Press, 2009. p. 705-17. (Methods in Molecular Biology, 542) ISBN 978-1-59745-561-9.

ADENOVIRUS ONCOLITICO ONYX-015; MITOMICINA-C; DOXORRUBICINA; QUIMIOTERAPIA COM CISPLATINA; SARCOMAS


127/399US=85 / Biol/Mol
Kim HS, Kang SB, Seo SS, Han SS, Kim JW, Park NH, Kang SB, Lee HP, Song YS. Phase I/IIa study of combination chemotherapy with CKD-602 and cisplatin in patients with recurrent epithelial ovarian cancer. In: Diederich M. Natural compounds and their role in apoptotic cell signaling pathways. Boston: Blackwell, 2009. p. 627-34. (Annals of the New York Academy of Sciences Vol 1171) ISBN 978-1-57331-737-5.

CANCER DE OVARIO; RECORRENTE; DRC-602; CISPLATINA


128/399Câncer
Silva LF, Corrêa LF, Pessoa AF, Lamas DO. Metastatic paratesticular liposarcoma: case report and literature review: case Report. Applied Cancer Research, São Paulo: Tecmedd, v.30, n.4, p. 353-5, 2010. ISSN 1980-5578.

Disponível em: http://accamargo.phlnet.com.br/applied/ACR201030p.353-5.pdf

LIPOSARCOMA; METASTASE NEOPLASICA; SARCOMA; NEOPLASIA TESTICULAR; NEOPLASIA UROLOGICA; REVISAO DE LITERATURA


129/399US=97 / Biol/Mol
Molls M, Nieder C, Belka C, Norum J. Quantitative cell kill of radio- and chemotherapy. In: Molls M, Vaupel P, Nieder C, Anscher MS. The impact of tumor biology on cancer treatment and multidisciplinary strategies. Baltimore: Springer, 2009. p. 169-90. (Medical Radiology Radiation Oncology) ISBN 978-3-540-74385-9.

CANCER; RADIOTERAPIA; QUIMIOTERAPIA; INTERACAO MOLECULAR


130/399US=97 / Biol/Mol
Nieder C. Mechanisms of treatment resistance: molecular and clinical examples for radio- and chemotherapy. In: Molls M, Vaupel P, Nieder C, Anscher MS. The impact of tumor biology on cancer treatment and multidisciplinary strategies. Baltimore: Springer, 2009. p. 243-50. (Medical Radiology Radiation Oncology) ISBN 978-3-540-74385-9.

RADIOTERAPIA; QUIMIOTERAPIA; MECANISMOS DE RESISTENCIA AO TRATAMENTO


131/399US=23-D / Câncer
Wong CYO. Surgically unresectable and chemotherapy-refractory metastatic liver carcinoma: treatment with yttrium-90 microsphere follwed by assessment with positron emission tomography. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 103-14. ISBN 978-1-4020-9803-1.

AVALIACAO ATRAVES DA TOMOGRAFIA POR EMISSAO DE POSITRONS; Y-90 RADIOEMBOLIZACAO MICROESFERA; CARCINOMA DE FIGADO IRRESSECAVEL CIRURGICAMENTE; QUIMIOTERAPIA-REFRATARIO METASTATICO; TRATAMENTO COM ITRIO-90 MICROESFERA FOLLWED


132/399US=45-B / Cab/Pesc
HU KS, Quon H, Harrison LB. Management of the neck: radiation therapy and chemotherapy. In: Harrison LB, Sessions RB, Hong WK. Head and neck cancer: a multidisciplinary approach. 3rd ed. Philadelphia: J B Lippincott, 2009. p. 204-31. ISBN 978-0-7817-7136-8.

CANCER DE CABECA E PESCOCO; CIRURGIA DO PESCOCO. TRATAMENTO; RADIOTERAPIA; QUIMIOTERAPIA; CANCER DE SEIO MAXILAR; CANCER DE OROFARINGE


133/399US=45-B / Cab/Pesc
Lee N, Chen AM. Cancer of the nasal cavity and paranasal sinus: radiation therapy and chemotherapy management: general principles and management. In: Harrison LB, Sessions RB, Hong WK. Head and neck cancer: a multidisciplinary approach. 3rd ed. Philadelphia: J B Lippincott, 2009. p. 475-90. ISBN 978-0-7817-7136-8.

CANCER DA CAVIDADE NASAL; CANCER DOS SEIOS PARANASAIS; RADIOTERAPIA; QUIMIOTERAPIA


134/399US=45-B / Cab/Pesc
O'Malley BB, Mukherji SK. Cancer of the nasal cavity and paranasal sinus: radiation theraphy and chemotherapy management: radiologic imaging concerns. In: Harrison LB, Sessions RB, Hong WK. Head and neck cancer: a multidisciplinary approach. 3rd ed. Philadelphia: J B Lippincott, 2009. p. 490-9. ISBN 978-0-7817-7136-8.

CANCER DE CABECA E PESCOCO; CANCER DA CAVIDADE NASAL; CANCER DOS SEIOS PARANASAIS; IMAGEM


135/399US=45-B / Cab/Pesc
Harrison LB, Woode R, Mendenhall WM. Cancer of the nasal cavity and paranasal sinus: radiation theraphy and chemotherapy management: radiation therapy technique. In: Harrison LB, Sessions RB, Hong WK. Head and neck cancer: a multidisciplinary approach. 3rd ed. Philadelphia: J B Lippincott, 2009. p. 500-1. ISBN 978-0-7817-7136-8.

CANCER DE CABECA E PESCOCO; CANCER DA CAVIDADE NASAL; CANCER DOS SEIOS PARANASAIS; RADIOTERAPIA


136/399US=9-A / Ginecologia
Markman M. Chemotherapy. In: Berek JS, Hacker NF. Berek and Hacker's gynecologic oncology. 5th ed. Philadelphia: Lippincott Williams & Wilkins, 2009. p. 57-82. ISBN 978-0-7817-9512-8.

ONCOLOGIA GINECOLOGICA; QUIMIOTERAPIA; CRESCIMENTO DO TUMOR; FATORES BIOLOGICOS; FATORES FARMACOLOGICOS; COMBINACAO QUIMIOTERAPICA; DROGAS ANTINEOPLASICAS


137/399US=19 / Cab/Pescoço
Hristov B, Gibson MK, Bajaj G. Early treatment with radiation and chemotherapy. In: Koch WM. Head and neck cancer. Philadelphia: Saunders Elsevier, 2010. p. 129-65. (Early diagnosis and treatment of cancer series) ISBN 978-1-4160-5202-9.

CANCER DE CABECA E PESCOCO; RADIOTERAPIA; QUIMIOTERAPIA; CARCINOMA IN SITU; DOENCA PRE-INVASIVA; CANCER DE LARINGE; CANCER DE GLOTE; CANCER GLOTICO; CANCER DE SUPRAGLOTE; CANCER SUPRAGLOTICO; CANCER DE OROFARINGE; CANCER OROFARINGEO; CANCER DA CAVIDADE ORAL; BRAQUITERAPIA; LEUCOPLASIA


138/399US=10 / Gastro
Scartozzi M, Pierantoni C, Pagliacci A, Cascinu S. Chemotherapy and radiotherapy in pancreatic cancer. In: Siquini W, editor. Surgical treatment of pancreatic diseases. New York: Springer, 2008. p. 481-500. ISBN 978-88-470-0855-7.

RADIOTERAPIA EM CANCER DE PANCREAS; QUIMIOTERAPIA; NEOADJUVANTE PARA CANCER DE PANCREAS. TRATAMENTO ADJUVANTE; QUIMIORADIOTERAPIA NA DOENCA LOCALMENTE AVANCADA; QUIMIOTERAPIA NA DOENCA AVANCADA; TERAPIA-ALVO EM CANCER DE PANCREAS AVANCADO


139/399US=10 / Urologia
Armstrong AJ, Carducci MA. Chemotherapy for advanced prostate cancer. In: Kirby RS, Partin AW, Parsons JK, Feneley MR. Treatment methods for early and advanced prostate cancer. New York: Informa Healthcare, 2008. p. 327-39. ISBN 978-0415-458933-1.

CANCER DE PROSTATA; QUIMIOTERAPIA; HORMONIO-REFRATARIO; AGENTES BIOLOGICOS


140/399US=103 / Câncer
O´Connor R, Breen L. Resistance to chemotherapy drugs. In: Missailidis S. Anticancer therapeutics. New Jersey: Wiley Blackwell, 2008. p. 263-81. ISBN 978-0-470-72303-6.

QUIMIOTERAPIA; RESISTENCIA AOS FARMACOS; RESISTENCIA AOS MECANISMOS DE QUIMIOTERAPIA; RESISTENCIA FARMACOCINETICA; RESISTENCIA FARMACODINAMICA


Primeira | Anterior | Próxima | Última